Metabolite

KNApSAcK Entry

id C00000750
Name Phenylacetic acid
CAS RN 103-82-2
Standard InChI InChI=1S/C8H8O2/c9-8(10)6-7-4-2-1-3-5-7/h1-5H,6H2,(H,9,10)
Standard InChI (Main Layer) InChI=1S/C8H8O2/c9-8(10)6-7-4-2-1-3-5-7/h1-5H,6H2,(H,9,10)

Cluster

Phytochemical cluster
KCF-S cluster No. 2481

Link

ChEMBL

By standard InChI CHEMBL1044
By standard InChI Main Layer CHEMBL1044

KEGG

By LinkDB C07086

CTD

By CAS RN C025136

Human Protein / Gene in interaction

3 ChEMBL Protein in interactions

accession description class description compound assay ID (# of activities) # of diseases
(OMIM / KEGG)
P15121 Aldose reductase Enzyme CHEMBL1044 CHEMBL924228 (1)
0 / 0
P27169 Serum paraoxonase/arylesterase 1 Enzyme CHEMBL1044 CHEMBL991845 (1)
1 / 0
P06239 Tyrosine-protein kinase Lck Src CHEMBL1044 CHEMBL706267 (1)
0 / 1

CTD interaction (14)

compound gene gene name gene description interaction interaction type form reference
pmid
C025136 5444 PON1
ESA
MVCD5
PON
paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81) 4-hydroxy-2-nonenal inhibits the reaction [PON1 protein results in increased hydrolysis of phenylacetic acid] decreases reaction
/ increases hydrolysis
protein 15375178
C025136 5444 PON1
ESA
MVCD5
PON
paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81) Arachidonic Acid inhibits the reaction [PON1 protein results in increased hydrolysis of phenylacetic acid] decreases reaction
/ increases hydrolysis
protein 15375178
C025136 5444 PON1
ESA
MVCD5
PON
paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81) [Ascorbic Acid co-treated with Copper Sulfate] inhibits the reaction [PON1 protein results in increased hydrolysis of phenylacetic acid] affects cotreatment
/ decreases reaction
/ increases hydrolysis
protein 15375178
C025136 5444 PON1
ESA
MVCD5
PON
paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81) [Ascorbic Acid co-treated with ferrous sulfate] inhibits the reaction [PON1 protein results in increased hydrolysis of phenylacetic acid] affects cotreatment
/ decreases reaction
/ increases hydrolysis
protein 15375178
C025136 5444 PON1
ESA
MVCD5
PON
paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81) Hydrogen Peroxide inhibits the reaction [PON1 protein results in increased hydrolysis of phenylacetic acid] decreases reaction
/ increases hydrolysis
protein 15375178
C025136 5444 PON1
ESA
MVCD5
PON
paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81) Linoleic Acid inhibits the reaction [PON1 protein results in increased hydrolysis of phenylacetic acid] decreases reaction
/ increases hydrolysis
protein 15375178
C025136 5444 PON1
ESA
MVCD5
PON
paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81) PON1 promoter SNP results in decreased hydrolysis of phenylacetic acid decreases hydrolysis
promoter 16117861
C025136 5444 PON1
ESA
MVCD5
PON
paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81) PON1 protein affects the metabolism of phenylacetic acid affects metabolic processing
protein 11304470
15924216
16079929
C025136 5444 PON1
ESA
MVCD5
PON
paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81) PON1 protein polymorphism affects the metabolism of phenylacetic acid affects metabolic processing
protein 15924216
C025136 5444 PON1
ESA
MVCD5
PON
paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81) PON1 protein results in increased hydrolysis of phenylacetic acid increases hydrolysis
protein 9746266
15375178
16052486
16117861
20176005
C025136 5444 PON1
ESA
MVCD5
PON
paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81) Pyruvaldehyde inhibits the reaction [PON1 protein results in increased hydrolysis of phenylacetic acid] decreases reaction
/ increases hydrolysis
protein 15375178
C025136 5445 PON2
paraoxonase 2 (EC:3.1.1.2 3.1.1.81) PON2 protein results in increased hydrolysis of phenylacetic acid increases hydrolysis
protein 16117861
C025136 5445 PON2
paraoxonase 2 (EC:3.1.1.2 3.1.1.81) PON2 protein SNP results in decreased hydrolysis of phenylacetic acid decreases hydrolysis
protein 16117861
C025136 5446 PON3
paraoxonase 3 (EC:3.1.1.2 3.1.8.1 3.1.1.81) PON3 protein results in increased hydrolysis of phenylacetic acid increases hydrolysis
protein 16099434
16139510

Related Disease

Diseases related to proteins in ChEMBL interactions

OMIM (1)

OMIM preferred title UniProt
#612633 Microvascular complications of diabetes, susceptibility to, 5; mvcd5 P27169

KEGG DISEASE (1)

KEGG disease name UniProt
H00093 Combined immunodeficiencies (CIDs) P06239 (related)